Skip to content
OpenCapital
Get started

McCormick & Company, Incorporated MKC Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1

Other financials

Income statement

See full
Revenue$1.9B+16.7%
Gross profit$708.9M+17.4%
Operating income$227.5M+1.0%
Net income$1.0B+526%
EPS (diluted)$3.77+528%

Balance sheet

See full
Cash & equivalents$177.7M+72.9%
Total debt$4.9B+38.3%
Total equity$7.0B+28.7%
Total assets$16.3B+26.7%

Cash flow

See full
Operating cash flow$50.9M-55.9%
CapEx$32.5M-12.4%
Free cash flow$18.4M-76.5%

Valuation

See full
Market cap$12.54B-13.9%
Enterprise value$17.28B-7.0%
P/E7.6×-10.9×
P/S1.8×-0.4×

Profitability

See full
Gross margin37.9%-0.6pp
Operating margin15.1%-0.5pp
Net margin23.1%+11.4pp
FCF margin9.6%0.0pp

Returns & leverage

See full
Return on equity26.5%+11.8pp
Debt / equity0.7×0.0×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by McCormick & Company, Incorporated in its filing.

Tagged under the XBRL concept us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1.

The official record: McCormick & Company, Incorporated’s 10-K, filed January 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about McCormick & Company, Incorporated's sharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average exercise price beginning balance1.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is McCormick & Company, Incorporated's sharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average exercise price beginning balance1?
McCormick & Company, Incorporated (MKC) reported sharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average exercise price beginning balance1 of $73.92 in Q3 2025.
How has McCormick & Company, Incorporated's sharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average exercise price beginning balance1 changed year-over-year?
McCormick & Company, Incorporated's sharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average exercise price beginning balance1 increased by 2.3% year-over-year, from $72.25 to $73.92.
What is the long-term trend for McCormick & Company, Incorporated's sharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average exercise price beginning balance1?
Over 5 years (2020 to 2025), McCormick & Company, Incorporated's sharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average exercise price beginning balance1 has grown at a 6.7% compound annual growth rate (CAGR), from $53.56 to $73.92.